Cantor Fitzgerald, L. P.
- SEC CIK
- 0001024896
- Latest filing
- Aug 19, 2026
TBPH holding history
Theravance Biopharma, Inc. in every 13F filed by Cantor Fitzgerald, L. P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −16,000−100.0% | Sold out | Holders |
| Q2 2024 | 16,000 | $135.7K | <0.1% | −2,000−11.1% | Reduced | Holders |
| Q1 2024 | 18,000 | $161.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 18,000 | $202.3K | <0.1% | −2,000−10.0% | Reduced | Holders |
| Q3 2023 | 20,000 | $172.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 20,000 | $207.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 20,000 | $217.0K | <0.1% | +20,000 | New | Holders |